PharmaTelevision - BIO: The Future

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: BIO: The Future

Visitors: You are watching a 5 minute preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

In this interview, Fintan Walton speaks with Jim Greenwood, the CEO of BIO, at their recent annual meeting in San Diego where over 20,000 attendees gathered from more than 70 countries around the world. They discuss what the future holds for the industry with the affects of the ongoing credit crunch and the upcoming U.S. presidential election. Mr. Greenwood agrees that, based on the voting records of both Senators Obama and McCain, whoever wins the election will certainly make one of their first acts the reversal of President Bush's restriction on embryonic stem cell research. In addition to that potentially monumental change, the industry also faces upcoming battles over patent reform in the U.S. courts and the appointment of a new FDA commissioner. Looking towards the future, Mr. Greenwood sees two of the most exciting areas for growth in the fields of gene silencing and the continued advancements in the area of biofuels production.

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

The prominent speakers at Biotechnology Industry Organization's convention.

Fintan Walton:

Hello and welcome to PharmaVentures Business Review here live at BIO in San Diego, California. On this show we have the honorable James Greenwood, who is the CEO and President of BIO. Welcome to the show.

James C. Greenwood:

Thank you. Thanks for having me.

Fintan Walton:

Pleasure. How has BIO gone this year?

James C. Greenwood:

Well this convention or..?

Fintan Walton:

Yes, this convention.

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

James C. Greenwood

President and Chief Executive Officer

He represented Pennsylvania's Eighth District in the U.S. House of Representatives from January 1993 through January 2005. A senior member of the Energy and Commerce Committee, he was widely viewed as a leader on health care and the environment. From 2001 to 2004, Mr. Greenwoodserved as Chairman of the Energy and Commerce Committee Subcommittee on Oversight and Investigation with oversight authority over issues in the full Committee's vast jurisdiction. Prior to his election to Congress, he served six years in the Pennsylvania General Assembly (1980-86) and six years in the Pennsylvania Senate (1986-1993). Mr. Greenwood graduated from Dickinson College in 1973 with a BA in Sociology. From 1977 until 1980, he worked as a caseworker with abused and neglected children at the Bucks County Children and Youth Social Service Agency.

Biotechnology Industry Organization

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. It has evolved into a world class advocacy organization playing a leading role in shaping public policy on a variety of fronts critical to the success of the biotechnology industry at the state and national levels as well as internationally. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. BIO also produces the annual BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.